Evidence map›Paper›PMID 37456249›Full record

ArticleFrontiers in oncology2023

Differentiating malignant and benign pleural effusion in patients with lung cancer: an

Weishan Zhang, Zhe Liu, Xiaoyi Duan, Yan Li, Cong Shen, Youmin Guo, Jian Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Weishan ZhangPET/CT Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhe LiuRadiology Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Xiaoyi DuanPET/CT Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Yan LiPET/CT Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Cong ShenPET/CT Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Youmin GuoPET/CT Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Jian YangRadiology Department of the First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
First Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale: To explore the clinical role of Methods: Over a 8-year period, we retrospectively reviewed PET/CT data of lung cancer patients with pleural effusion, with 237 participants enrolled for analysis. The nature of pleural effusion was confirmed using pleural cytology or biopsy. MPE versus BPE comparison and multiple regression analysis were performed. Receiver operating characteristic (ROC) curve analysis was used for evaluating the diagnostic performance. Results: Of the 237 participants, 170 had MPEs and 67 had BPEs. Compared with BPEs, MPEs had higher pleural SUVmax and thicker pleura and were more common among non-small cell lung cancers, peripheral tumors, and women (p < 0.05). BPEs had larger and higher Conclusion:

Indexed as

18F-fluorodeoxyglucoselung cancerPET/CTpleural effusionpleural metastasis

Identifiers

PMID37456249
PMCPMC10348711
OpenAlexW4382657080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.